Titelia

Holdings of Exome Asset Management LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
40 in 2 countries
Top ten
49.7 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Praxis Precision Medicines Inc 45,46914.6M $
2COGENT BIOSCIENCES INC 278,53310.7M $
3Enliven Therapeutics Inc 220,0918.6M $
4IONIS PHARMACEUTICALS INC 110,0648.3M $
5GUARDANT HEALTH INC 82,7367.6M $
6CYTOKINETICS INC 103,7186.8M $
7Eli Lilly & Co 7,0126.4M $
8ALUMIS INC 279,1766.2M $
9Bridgebio Pharma Inc 67,4925M $
10VERA THERAPEUTICS INC 114,9914.6M $
11Insmed Inc 26,6514.4M $
12Elevance Health Inc 14,6774.3M $
13Agios Pharmaceuticals Inc 125,0604.2M $
14United Therapeutics Corp 7,0534.2M $
15NATERA INC 18,6503.7M $
16Rhythm Pharmaceuticals Inc 40,5813.5M $
17UnitedHealth Group Inc 12,8623.5M $
18Apellis Pharmaceuticals Inc 85,5173.4M $
19VERASTEM INC 636,7003.4M $
2010X Genomics Inc 154,1943.3M $
21Boston Scientific Corp 48,3473M $
22Monte Rosa Therapeutics Inc 179,4843M $
23Intuitive Surgical Inc 6,3582.9M $
24ADAGENE INC 736,8452.9M $
25Arrowhead Pharmaceuticals Inc 45,7212.9M $
26Relay Therapeutics Inc 278,3022.8M $
27Maze Therapeutics Inc 88,5102.6M $
28CYTOMX THERAPEUTICS INC 521,4682.5M $
29AVALO THERAPEUTICS INC 159,3412.4M $
30Glaukos Corp 20,8742.2M $
31Corbus Pharmaceuticals Holdings Inc 234,1362.2M $
32Penumbra Inc 6,3002.1M $
33Soleno Therapeutics Inc 61,6732.1M $
34Liquidia Corp 45,7961.7M $
35ZENAS BIOPHARMA INC 80,7301.6M $
36NovaBridge Biosciences 576,9601.4M $
374D Molecular Therapeutics Inc 130,5641.2M $
38NEXTCURE INC 115,5001.2M $
39Palisade Bio Inc 600,0001.1M $
40Lipocine Inc 60,861486.3K $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Health care 25.6 %
  • Unattributed 74.4 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 97.3 %
  • Cayman Islands 2.7 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States38154.8M $97.29 %
2Cayman Islands24.3M $2.71 %
Cite this page

Titelia. "Holdings of Exome Asset Management LLC". https://titelia.com/en/funds/US13F2011932